Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011948 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Liushuai Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever Virus, Crimean-Congo, Hemorrhagic Fever, Crimean. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Hubei Natural Science Foundation for Distinguished Young Scholars.
Abstract (Originalsprache)
Crimean-Congo hemorrhagic fever virus (CCHFV) is a highly pathogenic tick-borne virus, prevalent in more than 30 countries worldwide. Human infection by this virus leads to severe illness, with an average case fatality of 40%. There is currently no approved vaccine or drug to treat the disease. Neutralizing antibodies are a promising approach to treat virus infectious diseases. This study generated 37 mouse-derived specific monoclonal antibodies against CCHFV Gc subunit. Neutralization assays using pseudotyped virus and authentic CCHFV identified Gc8, Gc13, and Gc35 as neutralizing antibodies. Among them, Gc13 had the highest neutralizing activity and binding affinity with CCHFV Gc. Consistently, Gc13, but not Gc8 or Gc35, showed in vivo protective efficacy (62.5% survival rate) against CCHFV infection in a lethal mouse infection model. Further characterization studies suggested that Gc8 and Gc13 may recognize a similar, linear epitope in domain II of CCHFV Gc, while Gc35 may recognize a different epitope in Gc. Cryo-electron microscopy of Gc-Fab complexes indicated that both Gc8 and Gc13 bind to the conserved fusion loop region and Gc13 had stronger interactions with sGc-trimers. This was supported by the ability of Gc13 to block CCHFV GP-mediated membrane fusion. Overall, this study provides new therapeutic strategies to treat CCHF and new insights into the interaction between antibodies with CCHFV Gc proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
- University of the Chinese Academy of Sciences, Beijing, China.
- Hubei Jiangxia Laboratory, Wuhan, China.
ORCID-Profile: Manli Wang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Hubei Natural Science Foundation for Distinguished Young Scholars
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Key Technologies Research and Development Program
- Science Fund for Distinguished Young Scholars of Hubei Province
Zitieren
APA
Li, L., Chong, T., Peng, L., Liu, Y., Rao, G., Fu, Y., Shu, Y., Shen, J., Xiao, Q., Liu, J., Li, J., Deng, F., Yan, B., Hu, Z., Cao, S., & Wang, M. (2024). Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011948
Vancouver
Li L, Chong T, Peng L, Liu Y, Rao G, Fu Y, et al. Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011948
BibTeX
@article{Li2024,
author = {Li, Liushuai and Chong, Tingting and Peng, Lu and Liu, Yajie and Rao, Guibo and Fu, Yan and Shu, Yanni and Shen, Jiamei and Xiao, Qinghong and Liu, Jia and Li, Jiang and Deng, Fei and Yan, Bing and Hu, Zhihong and Cao, Sheng and Wang, Manli},
title = {Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011948}
}
EUVIMED